Works about PROTEASE inhibitors

Results: 4878
    1
    2
    3
    4
    5

    Inhibition of Plasmepsin V Activity Demonstrates Its Essential Role in Protein Export, PfEMP1 Display, and Survival of Malaria Parasites.

    Published in:
    PLoS Biology, 2014, v. 12, n. 7, p. 1, doi. 10.1371/journal.pbio.1001897
    By:
    • Sleebs, Brad E.;
    • Lopaticki, Sash;
    • Marapana, Danushka S.;
    • O'Neill, Matthew T.;
    • Rajasekaran, Pravin;
    • Gazdik, Michelle;
    • Günther, Svenja;
    • Whitehead, Lachlan W.;
    • Lowes, Kym N.;
    • Barfod, Lea;
    • Hviid, Lars;
    • Shaw, Philip J.;
    • Hodder, Anthony N.;
    • Smith, Brian J.;
    • Cowman, Alan F.;
    • Boddey, Justin A.
    Publication type:
    Article
    6

    Enzymatic Blockade of the Ubiquitin-Proteasome Pathway.

    Published in:
    PLoS Biology, 2011, v. 9, n. 3, p. 1, doi. 10.1371/journal.pbio.1000605
    By:
    • Ernst, Robert;
    • Claessen, Jasper H. L.;
    • Mueller, Britta;
    • Sanyal, Sumana;
    • Spooner, Eric;
    • van der Veen, Annemarthe G.;
    • Kirak, Oktay;
    • Schlieker, Christian D.;
    • Weihofen, Wilhelm A.;
    • Ploegh, Hidde L.
    Publication type:
    Article
    7
    8

    Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.

    Published in:
    Liver International, 2016, v. 36, n. 2, p. 189, doi. 10.1111/liv.12964
    By:
    • Everson, Gregory T.;
    • Sims, Karen D.;
    • Thuluvath, Paul J.;
    • Lawitz, Eric;
    • Hassanein, Tarek;
    • Rodriguez ‐ Torres, Maribel;
    • Desta, Tadesse;
    • Hawkins, Trevor;
    • Levin, James M.;
    • Hinestrosa, Federico;
    • Rustgi, Vinod;
    • Schwartz, Howard;
    • Younossi, Zobair;
    • Webster, Lynn;
    • Gitlin, Norman;
    • Eley, Timothy;
    • Huang, Shu ‐ Pang;
    • McPhee, Fiona;
    • Grasela, Dennis M.;
    • Gardiner, David F.
    Publication type:
    Article
    9
    10

    Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis.

    Published in:
    Liver International, 2015, v. 35, n. 1, p. 90, doi. 10.1111/liv.12656
    By:
    • Calleja, Jose L.;
    • Pascasio, Juan M.;
    • Ruiz ‐ Antorán, Belén;
    • Gea, Francisco;
    • Bárcena, Rafael;
    • Larrubia, Juan R.;
    • Pérez ‐ Álvarez, Ramón;
    • Sousa, Jose M.;
    • Romero ‐ Gómez, Manuel;
    • Solá, Ricard;
    • Revilla, Juan;
    • Crespo, Javier;
    • Navarro, Jose M.;
    • Arenas, Juan I.;
    • Delgado, Manuel;
    • Fernández ‐ Rodríguez, Conrado M.;
    • Planas, Ramon;
    • Buti, Maria;
    • Forns, Xavier
    Publication type:
    Article
    11

    Boceprevir in liver transplant recipients.

    Published in:
    Liver International, 2015, v. 35, n. 1, p. 192, doi. 10.1111/liv.12548
    By:
    • Saab, Sammy;
    • Manne, Vignan;
    • Bau, Sherona;
    • Reynolds, Justin A.;
    • Allen, Ruby;
    • Goldstein, Leonard;
    • Durazo, Francisco;
    • El ‐ Kabany, Mohammed;
    • Han, Steven;
    • Busuttil, Ronald W.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Telaprevir user's guide.

    Published in:
    Liver International, 2012, p. 17, doi. 10.1111/j.1478-3231.2011.02708.x
    By:
    • Liapakis, Ann Marie;
    • Jacobson, Ira
    Publication type:
    Article
    29
    30
    31
    32

    Future treatment of patients with HCV cirrhosis.

    Published in:
    Liver International, 2012, p. 113, doi. 10.1111/j.1478-3231.2011.02702.x
    By:
    • Bourlière, Marc;
    • Khaloun, Asma;
    • Wartelle-Bladou, Claire;
    • Oules, Valérie;
    • Portal, Isabelle;
    • Benali, Souad;
    • Adhoute, Xavier;
    • Castellani, Paul
    Publication type:
    Article
    33
    34
    35
    36
    37

    What future for ribavirin?

    Published in:
    Liver International, 2009, v. 29, p. 68, doi. 10.1111/j.1478-3231.2008.01936.x
    By:
    • Shiffman, Mitchell L.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50